Huadong Medicine Co. Ltd.

Pharmaceuticals
China
Earnings Per Share Growth (%)45.40%
Cost of Goods Sold (US$ Millions)$2,543
Current Liabilities (US$ Millions)$1,055
Total Assets (US$ Millions)$1,379
Long Term Debt$200
Return on Equity48.39%
Revenue (US$ Millions)$3,345
Total Company Assets$1,758
Revenue Growth (%)14.67%
Net Income (US$ Millions)$169
Earnings Per Share (US$)$45.40
Total Equity (US$ Millions)$457
Profit Margin (%)5.05%
Debt To Equity Ratio (%)0.44%
Inventory Turnover$373